I already don't trust aspartame (found in EQUAL, yogurts, a bunch of "no-sugar" stuff, and in soft drinks) because Donald Rumsfeld used to be the CEO of Searle, the company that makes it. In fact, an article in Vanity Fair by Rich Cohen, which appears in the December 2005 Vanity Fair, Rumsfeld appears to have been the driving force behind FDA approval of aspartame. The FDA was reluctant to approve aspartame--because it seemed to be causing seizures in rats and people--but when Rumsfeld started working for the Reagan Administration, everything fell into place for the sugar substitute: If you're looking for weight loss (and there's no studies showing diet drinks do this) there's a better solution than cancer and/or imperiling the next generation (p.s. why doesn't the Pro-life movement jump on this?). Try some fresh water and lemon!For two decades, aspartame had failed to win approval. Then Ronald Reagan was elected president, and Donald Rumsfeld, while keeping his position at Searle, worked on the president-elect's interim foreign-policy team. Soon after Reagan was inaugurated, Searle re-applied for approval of aspartame. Within a few months, Reagan had named a new head of the FDA and the chemical got the green light. Rumsfeld had correctly recognized that Searle's problem was not scientific; it was political.
If that ain't enough to get you to drop your Diet Coke, check this out from NewsTarget:
A new study on aspartame conducted by the Ramazzini Foundation reveals that aspartame causes a dose-dependent increase in cancers (lymphomas, leukemias and breast cancers) when consumed at levels approaching those consumed by humans in diet soft drinks. Specifically, the study shows (reprinted from the abstract):
a) a significant dose-related increase of malignant tumor-bearing animals in males, in particular in the group treated at 2000 ppm; b) a significant increase of the incidence in lymphomas/leukemias in males treated at 2000 ppm and a significant dose-related increase of the incidence of lymphomas/leukemias in females, in particular in the group treated at 2000 ppm; c) a significant dose-related increase of the incidence of mammary cancer in females, in particular in the group treated at 2000 ppm. Conclusions. The results of this carcinogenicity bioassay not only confirm, but also reinforce the first experimental demonstration of [aspartame's] multipotential carcinogenicity at a dose level close to the acceptable daily intake (ADI) for humans. Furthermore, the study demonstrates that when lifespan exposure to [aspartame] begins during fetal life, its carcinogenic effects are increased.
The study, entitled "Lifespan Exposure to Low Doses of Aspartame Beginning During Prenatal Life Increases Cancer Effects in Rats" has been accepted for publication in the peer-reviewed journal Environmental Health Perspectives (EHP), the most widely-read environmental science journal in the world.
read more here.





